| Literature DB >> 34194395 |
Filipe G Andrade Godoi1,2, Isabel Forner-Piquer1, Basilio Randazzo1, Hamid R Habibi3, Fabiana L Lo Nostro4, Renata Guimarães Moreira2, Oliana Carnevali1,5.
Abstract
Di-isononyl phthalate (DiNP) is a plasticizer reported to elicit hormone-like activity and disrupt metabolism and reproduction in fish and other vertebrates. In general, phthalates have been used at high concentrations beyond reported environmental levels to assess their adverse effects on fish gonadal physiology. The present study exposed adult female zebrafish to a wide range of DiNP concentrations [0.42 µg L-1 (10-9 M), 4.2 µg L-1 (10-8 M), and 42 µg L-1 (10-7 M)] for 21 days. We evaluated gene expression profiles related to apoptosis, autophagy, and oxidative stress; DNA fragmentation (TUNEL assay: terminal deoxynucleotidyl transferase dUTP nick end labeling) and caspase activity (CAS3) were also examined. Exposure to 0.42 and 4.2 µg L-1 upregulated the genes coding for tnfa and baxa, sod1, prkaa1, respectively. CAS3 immunohistochemistry revealed a higher number of positive vitellogenic oocytes in ovaries exposed to 0.42 µg L-1. Subsequently, we examined the relationship between CAS3 signaling and DNA fragmentation. Accordingly, DNA fragmentation was observed in vitellogenic follicles of fish exposed to 0.42 and 4.2 μg L-1. Our results demonstrate that follicular atresia can occur after exposure to environmental levels of DiNP for 21 days, which may adversely affect the reproductive performance of female zebrafish in a non-monotonic manner.Entities:
Keywords: Danio rerio; Reproductive biomarkers; aquatic toxicology; endocrine disruption; follicular atresia; oxidative stress; phthalate
Mesh:
Substances:
Year: 2021 PMID: 34194395 PMCID: PMC8238463 DOI: 10.3389/fendo.2021.677853
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
List of primers for Real Time qPCR analysis.
| Type | Name | Abb. | Genbank accession number | FORWARD (5′-3′) | REVERSE (5′-3′) | Tm (°C) |
|---|---|---|---|---|---|---|
| Housekeeper | Ribosomal Protein Large P0 |
| NM_131580.2 | CTGAACATCTCGCCCTTCTC | TAGCCGATCTGCAGACACAC | 60 |
| Housekeeper | Ribosomal Protein Large P13 |
| NM_212784.1 | TCTGGAGGACTGTAAGAGGTATGC | AGACGCACAATCTTGAGAGCAG | 59 |
| Autophagy | Beclin 1, autophagy related |
| NM_200872.1 | GGACCACTTGGAACAACT | CCGAAGTTCTTCAGTGTCCATC | 60 |
| Autophagy | Microtubule-associated protein 1 light chain 3 |
| NM_200298.2 | GAGAAGTTTTTGCCGCCTCT | ACCTGTGTCCGAACATCTCC | 60 |
| Apoptosis | BCL2 associated X, apoptosis regulator a |
| NM_131562.2 | GGCTATTTCAACCAGGGTTCC | TGCGAATCACCAATGCTGT | 60 |
| Apoptosis | Apoptotic peptidase activating factor 1 |
| NM_131608.1 | TTCTACAGTAAACGCCCACC | TATCTAGTATTTCCCCATATTCC | 60 |
| Apoptosis | Caspase 3 |
| NM_131877.3 | CCGCTGCCCATCACTA | ATCCTTTCACGACCATCT | 60 |
| Apoptosis | BCL2 apoptosis regulator |
| NM_001030253.2 | CCTTCAATAAAGCAGTGGAGGAA | CGGGCTATCAGGCATTCAGA | 60 |
| Apoptosis | Tumor necrosis factor |
| NM_001002184.1 | TTGTGGTGGGGTTTGATG | TTGGGGCATTTTATTTTGTAAG | 60 |
| Autophagy | Mammalian Target of Rapamycin |
| NM_001077211.2 | AACCTACTGCCTCGACTTGC | CTCACAGCCACCACCAGTAG | 60 |
| Autophagy | UV radiation resistance associated gene |
| NM_201069.1 | GCGAGTGGAGGAGAGRGTATG | GCCGTGAGACCTCTTCAATC | 60 |
| Apoptosis | Fas ligand (TNF superfamily, member 6) |
| NM_001042701.2 | AGCCCGAGTCGAGATGAAGA | CAACTTGTTTCTGTGGGGCG | 60 |
| Autophagy | BH3 interacting domain death agonist |
| NM_001079826.1 | GCAGCAGCCAAAGAGTTTAAGAAGGAG | AGGTGTGCGTTCACAAACAGTCTTCA | 60 |
| Autophagy | Protein kinase AMP-activated, alpha 1 catalytic |
| NM_001110286.1 | GCACCTTCCACGCCTCCGATT | CCAGAGAGCCTTCCGCCACTTTAC | 60 |
| Apoptosis | Caspase 8 |
| MG958000.1 | GTTTTGGGCACAGATGGTAA | TACTGTGGCCATTCCGATCA | 60 |
| Oxidative stress | Superoxide dismutase 1 |
| AY195857 | CCGGACTATGTTAAGGCCATCT | ACACTCGGTTGCTCTCTTTTCTCT | 60 |
| Oxidative stress | Superoxide dismutase 2 |
| NM_199976.1 | GTCTGTTGGTTGGTCGCTTG | GCACCTAACAGGGGGTTGAA | 60 |
| Oxidative stress | Catalase |
| NM_130912.2 | AGGGCAACTGGGATCTTACA | TTTATGGGACCAGACCTTGG | 60 |
| Oxidative stress | Glutathione S-transferase, alpha tandem duplicate 1 |
| NM_213394.1 | TTGAGGAAAAGGCCAAAGTG | AACACGGCCTTCACTGTTCT | 60 |
| Endocrine | Glucocorticoid receptor |
| NM_001020711.3 | CGCCTTTAATCATGGGAGAA | AGACCTTGGTCCCCTTCACT | 58 |
| Oxidative stress | Glutathione reductase |
| NM_001020554.1 | GAACGGGGTCATATCGTGGT | TGGAGACCGACCACCTTTTC | 60 |
| Oxidative stress | Glutathione peroxidase 1a |
| NM_001007281.2 | ACCTGTCCGCGAAACTATTG | TGACTGTTGTGCCTCAAAG | 60 |
Transcriptional effects of DiNP on the zebrafish ovary.
| GENE | CTL | 0.42 μg L-1 | 4.2 μg L-1 | 42 μg L-1 |
|---|---|---|---|---|
|
| 2.09 ± 0.44 | 1.93 ± 0.17 | 1.77 ± 0.14 | 1.84 ± 0.34 |
|
| 1.42 ± 0.05 | 1.43 ± 0.06 | 1.43 ± 0.06 | 1.22 ± 0.07 |
|
| 1.73 ± 0.20 | 2.18 ± 0.19 | 2.74 ± 0.28** | 2.10 ± 0.31 |
|
| 1.65 ± 0.20 | 2.39 ± 0.28 | 2.20 ± 0.36 | 2.10 ± 0.30 |
|
| 1.88 ± 0.32 | 2.05 ± 0.25 | 2.59 ± 0.40 | 1.99 ± 0.19 |
|
| 2.02 ± 0.28 | 1.47 ± 0.15 | 2.22 ± 0.50 | 1.52 ± 0.17 |
|
| 7.24 ± 4.07 | 47.13 ± 16.89* | 11.29 ± 2.92 | 6.13 ± 2.96 |
|
| 2.46 ± 0.41 | 2.68 ± 0.17 | 2.46 ± 0.39 | 2.21 ± 0.20 |
|
| 3.62 ± 0.69 | 3.71 ± 0.37 | 4.81 ± 0.64 | 3.90 ± 0.56 |
|
| 3.23 ± 0.74 | 2.21 ± 0.20 | 2.45 ± 0.47 | 2.18 ± 0.41 |
|
| 1.29 ± 0.18 | 1.48 ± 0.13 | 1.26 ± 0.09 | 1.52 ± 0.12 |
|
| 1.72 ± 0.24 | 1.75 ± 0.10 | 2.60 ± 0.12** | 1.75 ± 0.13 |
|
| 1.47 ± 0.18 | 2.20 ± 0.37 | 2.35 ± 0.48 | 2.07 ± 0.31 |
|
| 1.65 ± 0.22 | 2.12 ± 0.16 | 2.74 ± 0.15** | 2.21 ± 0.22 |
|
| 1.25 ± 0.06 | 1.44 ± 0.12 | 1.37 ± 0.10 | 1.31 ± 0.10 |
|
| 2.34 ± 0.38 | 2.79 ± 0.23 | 3.16 ± 0.46 | 2.22 ± 0.20 |
|
| 17.60 ± 2.91 | 10.52 ± 3.09 | 11.62 ± 3.96 | 12.71 ± 1.14 |
|
| 3.47 ± 1.09 | 2.65 ± 0.42 | 2.10 ± 0.56 | 3.24 ± 0.75 |
|
| 1.83 ± 0.28 | 2.11 ± 0.42 | 1.51 ± 0.05 | 1.71 ± 0.27 |
|
| 2.08 ± 0.15 | 1.99 ± 0.11 | 1.75 ± 0.28 | 1.54 ± 0.13 |
Data were normalized against the expression of rplp0 and rplp13.
Data are reported as mean dCt ± SEM.
Asterisk superscript (*) indicates significant differences between control group (CTL) and DiNP treatment (one-way ANOVA, Dunnett’s multiple comparison test, *p < 0.05, **p < 0.01).
Genes: becn 1, Beclin 1 multifactorial protein; map1lc3c, microtubule-associated protein 1 light chain 3; bax, bcl2 associated X; apaf1, apoptotic peptidase activating factor 1; casp3, caspase 3; bcl 2, BCL2 apoptosis regulator; tnfa, tumor necrosis factor a; mtor, mammalian target of rapamycin; uvrag, UV irradiation resistance-associated tumor suppressor; faslg, Fas ligand; bid, BH3 interacting domain death agonist; prkaa1, protein kinase AMP-activated alpha 1 catalytic; casp8, caspase 8; sod1, superoxide dismutase 1; sod2, superoxide dismutase 2; cat, catalase; gst a1, glutathione transferase; nr3c1, glucocorticoid receptor gene; gsr, glutathione reductase; gpx1a, glutathione peroxidase.
Figure 1Gene expression heatmap (autophagy, apoptosis and oxidative stress) from zebrafish ovaries exposed to DINP. Color code to represented upregulated genes (green) and downregulated genes (red). Both rows (genes) and columns (treatments) were grouped by hierarchical clustering.
Figure 2TUNEL assay in ovaries sections from zebrafish exposed to DiNP for 21 days. Positive TUNEL reaction stained in red (arrowheads). CTL (A); 0.42 μg L−1 DiNP (B); 4.2 μg L−1 DiNP (C); 42 μg L−1 DiNP (D). Scale bar: 20 μm.
Figure 3Immunolocalization of CAS3 (ir-CAS3) in ovaries cross-sections from control and exposed zebrafish for 21 days to DiNP. CTL (A), 0.42 μg L−1 DiNP (B), 4.2 μg L−1 DiNP (C), 42 μg L−1 DiNP (D). CAS3 signal in green (arrowheads) and DAPI nuclei counterstaining in blue. Scale bar: 100 μm; insert in (B, C) 20 μm; insert in (D) 50 μm.
Relative frequency of CAS3 signal on vitellogenic follicles stage III (VF III), vitellogenic follicles stage IV (VF IV) and atretic follicles (AF) in zebrafish ovaries exposed to DiNP.
| VF III | VF IV | AF | |
|---|---|---|---|
| CTL | 14.29% | 42.86% | 42.86% |
| 0.42 μg L−1 | 33.33%* | 38.89% | 27.78% |
| 4.2 μg L−1 | 13.33% | 60.00% | 26.67% |
| 42 μg L−1 | 16.67% | 50.00% | 33.33% |
Asterisk superscript (*) indicates significant differences between control group (CTL) and DiNP treatments (glm test, *p < 0.05).